Bristol spin-out Revolymer seeks market approval for nicotine gum products.

Nicotine gum manufacturer Revolymer, a spin-out of Bristol University, has filed for market authorisation in Europe to sell its primary products with the Medicines and Healthcare products Regulatory Agency (MHRA).

If approved, the company will begin marketing its 2mg and 4mg strength gum in the UK, Ireland, Poland, and Spain.

The company, which also makes other polymer based consumer products and is backed by commercialisation firm the IP Group and commercialisation partnership SETsquared, was founded in 2005. Since then, it…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?